Literature DB >> 20339135

Stromal depletion goes on trial in pancreatic cancer.

Ken Garber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20339135     DOI: 10.1093/jnci/djq113

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  26 in total

Review 1.  Cholangiocarcinoma: molecular pathways and therapeutic opportunities.

Authors:  Sumera Rizvi; Mitesh J Borad; Tushar Patel; Gregory J Gores
Journal:  Semin Liver Dis       Date:  2014-11-04       Impact factor: 6.115

2.  Matricellular proteins osteopontin and osteonectin/SPARC in pancreatic carcinoma.

Authors:  Anne M Delany
Journal:  Cancer Biol Ther       Date:  2010-07-01       Impact factor: 4.742

Review 3.  The use of genomic information to optimize cancer chemotherapy.

Authors:  Federico Innocenti; Nancy J Cox; M Eileen Dolan
Journal:  Semin Oncol       Date:  2011-04       Impact factor: 4.929

4.  Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis.

Authors:  Katherine T Ostapoff; Bercin Kutluk Cenik; Miao Wang; Risheng Ye; Xiaohong Xu; Desiree Nugent; Moriah M Hagopian; Mary Topalovski; Lee B Rivera; Kyla D Carroll; Rolf A Brekken
Journal:  Cancer Res       Date:  2014-07-24       Impact factor: 12.701

Review 5.  Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting.

Authors:  Alphonse E Sirica; Gregory J Gores
Journal:  Hepatology       Date:  2014-04-09       Impact factor: 17.425

6.  Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines.

Authors:  Jonathan P Celli; Nicolas Solban; Alvin Liang; Stephen P Pereira; Tayyaba Hasan
Journal:  Lasers Surg Med       Date:  2011-09       Impact factor: 4.025

7.  Stromal interactions as regulators of tumor growth and therapeutic response: A potential target for photodynamic therapy?

Authors:  Jonathan P Celli
Journal:  Isr J Chem       Date:  2012-07-24       Impact factor: 3.333

8.  Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma.

Authors:  Parvin F Peddi; May Cho; Jian Wang; Feng Gao; Andrea Wang-Gillam
Journal:  J Gastrointest Oncol       Date:  2013-12

9.  Longitudinal measurement of extracellular matrix rigidity in 3D tumor models using particle-tracking microrheology.

Authors:  Dustin P Jones; William Hanna; Hamid El-Hamidi; Jonathan P Celli
Journal:  J Vis Exp       Date:  2014-06-10       Impact factor: 1.355

10.  Porous silicon nanocarriers for dual targeting tumor associated endothelial cells and macrophages in stroma of orthotopic human pancreatic cancers.

Authors:  Kenji Yokoi; Biana Godin; Carol J Oborn; Jenolyn F Alexander; Xuewu Liu; Isaiah J Fidler; Mauro Ferrari
Journal:  Cancer Lett       Date:  2012-09-18       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.